Billed with COVID-19 codes
For commercial members, as of 09/12/2023, COVID-19 vaccines will be commercially available and covered by HMSA.
| COVID-19 Vaccines codes | COVID-19 Vaccine description | COVID-19 Vaccine Administration |
|---|
91304 Novavax | SARSCOV2 VACCINE 5 MCG/0.5 ML IM USE | 90480 ADMIN SARSCOV2 VACC 1 DOSE |
91318 Pfizer-BioNTech (6 month through 4 years) | SARSCOV2 VACCINE 3MCG TRS-SUC IM |
91319 Pfizer-BioNTech (5 years through 11 years) | SARSCV2 VACCINE 10MCG TRS-SUC IM |
91320 Pfizer-BioNTech (12 years and older) | SARSCV2 VACCINE 30MCG TRS-SUC IM |
91321 Moderna (6 months through 11 years) | SARSCOV2 VACCINE 25 MCG/.25ML IM |
91322 Moderna (12 years and older) | SARSCOV2 VACCINE 50 MCG/0.5ML IM |
91323 Moderna (12 years and older) | SARSCOV2 VAC 10 MCG/0.2ML IM |
The original monovalent vaccines’ emergency use authorization (EUA) has been rescinded and those vaccines are no longer recommended for use, effective November 1, 2023, see COVID-19 vaccine & vaccine administration table.
| Deleted Codes as of November 1, 2023 |
| COVID-19 Vaccines | COVID-19 Administration Vaccine Codes |
Pfizer-BioNTech COVID-19, Comirnaty (CPT 91300) | 0001A (1st Dose) |
| 0002A (2nd Dose) |
| 0003A (3rd Dose) |
| 0004A (Booster Dose) |
Moderna COVID-19 (CPT 91301) | 0011A (1st Dose) |
| 0012A (2nd Dose) |
| 0013A (3rd Dose) |
Janssen COVID-19 (CPT 91303) | 0031A (1 Dose only) |
| 0034A (Booster Dose) |
| N/A | 0041A (1st Dose) |
| 0042A (2nd Dose) |
| 0044A (Booster Dose) |
Pfizer-BioNTech (CPT 91305) | 0051A (1st Dose) |
| 0052A (2nd Dose) |
| 0053A (3rd Dose) |
| 0054A (Booster Dose) |
Moderna COVID-19 (Booster) (CPT 91306) | 0064A (Booster Dose) |
Pfizer-BioNTech COVID-19 (CPT 91307) Pediatric Use 5 years through 11 years of age | 0071A (1st Dose) |
| 0072A (2nd Dose) |
| 0073A (3rd Dose) |
| 0074A (Booster Dose) |
Pfizer-BioNTech COVID-19 (CPT 91308) Pediatric Use 6 months through 5 years of age | 0081A (1st Dose) |
| 0082A (2nd Dose) |
| 0083A (3rd Dose) |
Moderna COVID-19 (Booster) (CPT 91309) | 0091A (1st Dose) |
| 0092A (2nd Dose) |
| 0093A (3rd Dose) |
| 0094A (Booster Dose) |
Moderna COVID-19 (CPT 91311) Pediatric Use 6 months through 5 years of age | 0111A (1st Dose) |
| 0112A (2nd Dose) |
| 0113A (3rd Dose) |
Pfizer-BioNTech COVID-19 (Bivalent) (CPT 91312) | 0121A (Single Dose) 0124A (Additional Dose) |
Moderna COVID-19 (Bivalent) (CPT 91313) | 0134A (Additional Dose) |
Moderna COVID-19 (Bivalent) (CPT 91314) Pediatric Use 6 years through 11 years of age | 0141A (1st Dose) 0142A (2nd Dose) 0144A (Additional Dose) |
Pfizer-BioNTech COVID-19 (Bivalent) (CPT 91315) Pediatric Use 5 years through 11 years of age | 0151A (Single Dose) 0154A (Additional Dose) |
Moderna COVID-19 (Bivalent) (CPT 91316) Pediatric Use 6 months through 5 years of age | 0164A (Additional Dose) |
Pfizer-BioNTech COVID-19 (Bivalent) (CPT 91317) Pediatric Use 6 months through 4 years of age | 0171A (1st Dose) 0172A (2nd Dose) 0173A (3rd Dose) 0174A (Additional Dose) |
IMPORTANT NOTE:
During the public health emergency (PHE) period, COVID-19 vaccine administration payments will go out to the provider. To avoid payment delays, we encourage that you bill COVID-19 vaccine administration separately from other services. Fully insured HMSA member’s cost-sharing (copayment, coinsurance, or deductible) shall be waived. According to Noridian, UB claims billed for COVID-19 vaccine administration shall be billed with revenue code 0771 (Preventive Care Services-Vaccine Administration). Using other revenue codes may result to bundling into a case rate.
In addition the following code combinations will be processed as follows:
| CPT Codes | HCPCS Codes |
| 90471 |
G0008-G0010
Note: If one of the above referenced vaccine specific HCPCS codes is billed with 90471, which is not specific, 90471 will be denied. If 90471 does not represent a duplicate of the service described by HCPCS code, modifier 59 may be to the 90471 code. In addition a diagnosis code specific to the disease for which the prophylactic vaccine is being administered, it should be linked to 90471.
|
| 90472 |
G0008-G0010
Note: Payment will not be made for 90472 when billed together with the referenced vaccine specific HCPCS codes.
|
Modifiers
When billing for immunization administration with Evaluation & Management (E/M) services, it is important to bill accurately.
When the immunization administration code is billed with an E/M visit, a modifier code must be appended to the E/M code to ensure that both services are paid when appropriate. Modifier 25 would generally be used for this purpose, if criteria for the use of this modifier are met.
In other cases, modifier code 59 may be needed to distinguish one immunization administration from another.
Please review the criteria for the use of modifiers 25 and 59.
Modifier Code 25
Modifier Code 59
The use of modifier 25 stipulates that the E/M service performed was a significant, separately identifiable service above and beyond the other service provided. HMSA recognizes that there is some degree of E/M performed in a physician's office when an immunization is administered. But this would not be considered significant when the patient's sole purpose for the visit is to receive the immunization. An example might be an older adult, basically in good health, who goes to his or her physician for an annual flu shot. No other services are rendered. In this case, only the immunization should be billed.
Modifier codes should only be used when the service meets the criteria described in CPT and HMSA's policies. HMSA will perform postpayment reviews of modifier usage as needed to verify modifiers were used as described. If postpayment review indicates that modifiers were not used appropriately, HMSA will request return of any overpayment. See Benefit Overpayment.